Hao Zhang and colleagues developed a novel fecal biomarker panel consisting of five immune-related proteins—CAT, LTF, MMP9, RBP4, and SERPINA3—that exhibit significant diagnostic accuracy for colorectal cancer (CRC). Here, RBP4 is linked to colorectal carcinoma.